Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: FIBRALIGN CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2019-02-07 to 2022-10-06
Current total value of award: $996609.36
Description: RESEARCH AND DEVELOPMENT FOR DHA SBIR PH II H2-0402 PROJECT AWARD TITLED, ALIGNED NANOFIBRILLAR SCAFFOLD ACTIVATED WITH HGF-MMRNA IN COMBINATION WITH MINCED MUSCLE GRAFT FOR TREATING VOLUMETRIC MUSCLE LOSS (VML) INJURY